SoftOx Solutions AS announces the resignations of board members Eskil Zapffe and
Henrik J. Nielsen, effective 30th of May 2025. Henrik Nielsen has assumed the
role of Chairman of the Board at SoftOx Wound & Skin Care AS, and Zapffe's
departure aligns with the successful execution of the wound care spin-out
process. The Company is grateful for their invaluable service and contributions
to advancing our technology and development. 

For further information, please contact: 
Ulrik Spork, COB Soft Solutions AS, +45 31 38 83 87 
Ingrid Juven, CFO SoftOx Solutions AS, +47 918 76 165 
Mail: ir@soft-ox.com  
 
About SoftOx Solutions AS: 
SoftOx Solutions AS (ticker: SOFTX) is a clinical-stage pharmaceutical company
listed on Euronext Growth Oslo. The company is developing highly effective
pan-antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi. The
technology is based on extensive research and development in partnership with
leading Nordic research institutes.